Dataset Information


Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response.

ABSTRACT: Intrauterine and neonatal manifestations of congenital long QT syndrome are associated with a high cardiac risk, particularly when atrioventricular block and excessive QT prolongation (> 600 ms(1/2)) are present. In a female newborn with these features, treatment with propranolol and mexiletine led to complete reduction of arrhythmia that was maintained 1.5 years later. High throughput genetic analysis found a sodium channel gene (LQT3) mutation. Disappearance of the 2:1 atrioventricular block and QTc shortening (from 740 ms(1/2) to 480 ms(1/2)), however, was achieved when mexiletine was added to propranolol. This effect was considered to be possibly genotype related. Early onset forms of long QT syndrome may benefit from advanced genotyping.

PROVIDER: S-EPMC1768001 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC8672658 | BioStudies
| S-EPMC2725366 | BioStudies
| S-EPMC8422972 | BioStudies
2013-01-01 | S-EPMC4151528 | BioStudies
| S-EPMC7679474 | BioStudies
| S-EPMC2682617 | BioStudies
| S-EPMC5119553 | BioStudies
| S-EPMC6588292 | BioStudies
| S-EPMC5421403 | BioStudies
| S-EPMC5840852 | BioStudies